Polycystic ovary syndrome
Conditions
Interventions
Test group:conbined treatment of traditional chinese medicine and western medicine
control group:Comparison with Western Medicine Treatment
Sponsors
Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the above traditional Chinese medicine syndrome differentiation and Western medicine diagnostic criteria. (2) Patients with combined hyperandrogenism (elevated levels of testosterone, free testosterone, androstenedione, and dehydroepiandrosterone sulfate can be included). (3) Individuals between the ages of 18 and 40 (including 18 and 40) who have a desire to have children. (4) Patients who are willing to accept experimental and control measures, sign informed consent forms, and are eligible for follow-up.
Exclusion criteria
Exclusion criteria: (1) Those who have been ineffective in using trastuzumab to induce ovulation in the past. (2) Menstrual disorders caused by organic lesions of the reproductive organs (such as uterine fibroids, adenomyosis, pituitary tumors, etc.) after examination. (3) Suffering from adrenal hyperplasia syndrome, thyroid disease, or tumors, etc; Functional uterine bleeding; Primary diabetes and endocrine disorders; There are other causes of hyperandrogenism. (4) Patients with primary diseases such as liver and kidney, cardiovascular, cerebrovascular, and hematopoietic systems, as well as psychiatric disorders. (5) Allergic constitution, such as a history of allergies to two or more drugs or foods; Or those who are allergic to known ingredients of this medicine. (6) Patients who are currently participating in clinical trials of other drugs. (7) Those who cannot cooperate with treatment and cannot be followed up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| testosterone;Pregnancy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| ovulation rate;HOMA-IR;Traditional Chinese Medicine Syndrome Score; | — |
Countries
China
Contacts
Public ContactXin Mingwei
Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University
Outcome results
None listed